FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4363645402> ?p ?o ?g. }

• W4363645402 abstract "Venetoclax is frequently used as salvage treatment in pediatric, adolescent, and young adult (AYA) patients with advanced hematologic malignancies. However, more data are needed from real-world studies to guide the safe and appropriate use of venetoclax in this population.We retrospectively reviewed the medical records of all patients diagnosed with hematologic malignancies less than 30 years of age treated with venetoclax outside of clinical trials at the University of California San Francisco Benioff Children's Hospitals from 2016 to 2022.We identified 13 patients (acute myeloid leukemia, n = 8; B-acute lymphoblastic leukemia, n = 3; myelodysplastic syndrome, n = 2) aged 4 months to 27 years. A median of 3 prior lines of therapy weregiven (range 0-5). All patients received venetoclax in combination with either a hypomethylating agent or conventional chemotherapy. Three (23%) patients achieved complete remission (CR); two (15%) achieved partial remission (PR); 3 (23%) had stable disease (SD), and five (42%) had progressive disease. Median survival and time to progression from venetoclax initiation was 9 months (range 2.5-52 months) and 3 months (range 2 weeks to 7.5 months), respectively. Six patients (46%) developed grade 3 or higher infections while receiving venetoclax, including bacteremia due to atypical organisms, invasive pulmonary infections with Aspergillus, cytomegalovirus (CMV) viremia, skin infections, and encephalitis with bacterial brain abscesses.Venetoclax in combination with hypomethylating agents or cytotoxic chemotherapy was effective in a subset of pediatric/AYA patients with advanced hematologic malignancies, but multiple severe infections were observed, particularly among patients who received venetoclax in combination with chemotherapy. Prospective studies will be required to determine the optimal dose and duration of venetoclax in this population." @default.
• W4363645402 created "2023-04-11" @default.
• W4363645402 creator A5001256603 @default.
• W4363645402 creator A5007078872 @default.
• W4363645402 creator A5015417146 @default.
• W4363645402 creator A5018365454 @default.
• W4363645402 creator A5028407091 @default.
• W4363645402 creator A5053709403 @default.
• W4363645402 creator A5069053611 @default.
• W4363645402 creator A5074978584 @default.
• W4363645402 creator A5084422354 @default.
• W4363645402 creator A5086455843 @default.
• W4363645402 creator A5088208241 @default.
• W4363645402 date "2023-04-10" @default.
• W4363645402 modified "2023-10-16" @default.
• W4363645402 title "Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies" @default.
• W4363645402 cites W2021663709 @default.
• W4363645402 cites W2077031414 @default.
• W4363645402 cites W2121565126 @default.
• W4363645402 cites W2250451640 @default.
• W4363645402 cites W2481182703 @default.
• W4363645402 cites W2517675534 @default.
• W4363645402 cites W2549463667 @default.
• W4363645402 cites W2555272704 @default.
• W4363645402 cites W2774533007 @default.
• W4363645402 cites W2783500974 @default.
• W4363645402 cites W2793886497 @default.
• W4363645402 cites W2803992642 @default.
• W4363645402 cites W2922692686 @default.
• W4363645402 cites W2980400657 @default.
• W4363645402 cites W2983001328 @default.
• W4363645402 cites W2987877754 @default.
• W4363645402 cites W2997806446 @default.
• W4363645402 cites W3011638072 @default.
• W4363645402 cites W3037299043 @default.
• W4363645402 cites W3046395109 @default.
• W4363645402 cites W3080879632 @default.
• W4363645402 cites W3131213086 @default.
• W4363645402 cites W3135688349 @default.
• W4363645402 cites W3211725527 @default.
• W4363645402 cites W4200474412 @default.
• W4363645402 cites W4289785528 @default.
• W4363645402 cites W4310096202 @default.
• W4363645402 doi "https://doi.org/10.1002/pbc.30335" @default.
• W4363645402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37036306" @default.
• W4363645402 hasPublicationYear "2023" @default.
• W4363645402 type Work @default.
• W4363645402 citedByCount "1" @default.
• W4363645402 countsByYear W43636454022023 @default.
• W4363645402 crossrefType "journal-article" @default.
• W4363645402 hasAuthorship W4363645402A5001256603 @default.
• W4363645402 hasAuthorship W4363645402A5007078872 @default.
• W4363645402 hasAuthorship W4363645402A5015417146 @default.
• W4363645402 hasAuthorship W4363645402A5018365454 @default.
• W4363645402 hasAuthorship W4363645402A5028407091 @default.
• W4363645402 hasAuthorship W4363645402A5053709403 @default.
• W4363645402 hasAuthorship W4363645402A5069053611 @default.
• W4363645402 hasAuthorship W4363645402A5074978584 @default.
• W4363645402 hasAuthorship W4363645402A5084422354 @default.
• W4363645402 hasAuthorship W4363645402A5086455843 @default.
• W4363645402 hasAuthorship W4363645402A5088208241 @default.
• W4363645402 hasConcept C104317684 @default.
• W4363645402 hasConcept C126322002 @default.
• W4363645402 hasConcept C143998085 @default.
• W4363645402 hasConcept C150194340 @default.
• W4363645402 hasConcept C185592680 @default.
• W4363645402 hasConcept C187212893 @default.
• W4363645402 hasConcept C190727270 @default.
• W4363645402 hasConcept C2776012956 @default.
• W4363645402 hasConcept C2776694085 @default.
• W4363645402 hasConcept C2777938653 @default.
• W4363645402 hasConcept C2778461978 @default.
• W4363645402 hasConcept C2779675984 @default.
• W4363645402 hasConcept C2780007613 @default.
• W4363645402 hasConcept C2780817109 @default.
• W4363645402 hasConcept C55493867 @default.
• W4363645402 hasConcept C71924100 @default.
• W4363645402 hasConceptScore W4363645402C104317684 @default.
• W4363645402 hasConceptScore W4363645402C126322002 @default.
• W4363645402 hasConceptScore W4363645402C143998085 @default.
• W4363645402 hasConceptScore W4363645402C150194340 @default.
• W4363645402 hasConceptScore W4363645402C185592680 @default.
• W4363645402 hasConceptScore W4363645402C187212893 @default.
• W4363645402 hasConceptScore W4363645402C190727270 @default.
• W4363645402 hasConceptScore W4363645402C2776012956 @default.
• W4363645402 hasConceptScore W4363645402C2776694085 @default.
• W4363645402 hasConceptScore W4363645402C2777938653 @default.
• W4363645402 hasConceptScore W4363645402C2778461978 @default.
• W4363645402 hasConceptScore W4363645402C2779675984 @default.
• W4363645402 hasConceptScore W4363645402C2780007613 @default.
• W4363645402 hasConceptScore W4363645402C2780817109 @default.
• W4363645402 hasConceptScore W4363645402C55493867 @default.
• W4363645402 hasConceptScore W4363645402C71924100 @default.
• W4363645402 hasFunder F4320306589 @default.
• W4363645402 hasFunder F4320332161 @default.
• W4363645402 hasIssue "6" @default.
• W4363645402 hasLocation W43636454021 @default.
• W4363645402 hasLocation W43636454022 @default.
• W4363645402 hasOpenAccess W4363645402 @default.
• W4363645402 hasPrimaryLocation W43636454021 @default.

• next